Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.28 USD | +0.17% | -2.54% | -18.11% |
06:19pm | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
02:56pm | BMO Capital Adjusts Price Target on Gilead Sciences to $80 From $89 | MT |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.